OrbiMed Advisors Israel II, Director: ADARx Pharmaceuticals ADRX Buy · Filed 09/30

Trade details

Type: Insider buy
Amount: $9,999,995
Shares · price: 588,235 sh · $17.00 a share
Held after: 588,235 sh
Stock: ADARx Pharmaceuticals ADRX
Person: OrbiMed Advisors Israel IIDirector
Trade date: 26/09/28
Filed: 26/09/30
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 7 insiders

ADARx Pharmaceuticals trades, last 26 weeks

What else happened in ADARx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 08/29~10/28

OrbiMed Advisors Israel II's recent trades

OrbiMed Advisors Israel IIDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
OrbiMed Advisors Israel IIDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
OrbiMed Advisors Israel II10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
OrbiMed Advisors Israel II10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08
OrbiMed Advisors Israel II10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$191.5K
29,319 sh
$191.5K
Filed 04/09
Traded 04/07